Cargando…
Hyperglycemia-Induced Platelet Activation in Type 2 Diabetes Is Resistant to Aspirin but Not to a Nitric Oxide–Donating Agent
OBJECTIVE: Acute, short-term hyperglycemia enhances high shear stress–induced platelet activation in type 2 diabetes. Several observations suggest that platelets in type 2 diabetes are resistant to inhibition by aspirin. Our aim was to assess comparatively the effect of aspirin, a nitric oxide–donat...
Autores principales: | Gresele, Paolo, Marzotti, Stefania, Guglielmini, Giuseppe, Momi, Stefania, Giannini, Silvia, Minuz, Pietro, Lucidi, Paola, Bolli, Geremia B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875435/ https://www.ncbi.nlm.nih.gov/pubmed/20299485 http://dx.doi.org/10.2337/dc09-2013 |
Ejemplares similares
-
Platelet dysfunction in platelet-type von Willebrand disease due to the constitutive triggering of the Lyn-PECAM1 inhibitory pathway
por: Bury, Loredana, et al.
Publicado: (2021) -
Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes Mellitus
por: Porcellati, Francesca, et al.
Publicado: (2011) -
Platelets and Airway Diseases
por: Momi, Stefania, et al.
Publicado: (2017) -
Pharmacokinetics and Pharmacodynamics of Therapeutic Doses of Basal Insulins NPH, Glargine, and Detemir After 1 Week of Daily Administration at Bedtime in Type 2 Diabetic Subjects: A randomized cross-over study
por: Lucidi, Paola, et al.
Publicado: (2011) -
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo
por: Momi, Stefania, et al.
Publicado: (2009)